Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Japan · Delayed Price · Currency is JPY

264.00

-4.00 (-1.49%)

Jun 19, 2026, 3:30 PM JST

6.45% (1Y)

Market Cap	13.27B +3.2%
Revenue (ttm)	6.16B +1.6%
Net Income	536.00M -25.3%
EPS	10.67 -25.4%
Shares Out	50.25M
PE Ratio	24.75
Forward PE	17.98
Dividend	3.50 (1.33%)
Ex-Dividend Date	Dec 29, 2025

Volume	25,600
Open	266.00
Previous Close	268.00
Day's Range	263.00 - 268.00
52-Week Range	245.00 - 444.00
Beta	0.32
Analysts	n/a
Price Target	3,300.00 (+1,150.0%)
Earnings Date	Aug 14, 2026

About Taiko Pharmaceutical

Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incor... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1946

Employees 220

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4574

Full Company Profile

Financial Performance

In 2025, Taiko Pharmaceutical's revenue was 6.40 billion, an increase of 1.67% compared to the previous year's 6.29 billion. Earnings were 923.00 million, an increase of 2.78%.

Financial Statements